title: Idiopathic gonadotrophin deficiency: genetic questions addressed through phenotypic characterization.
abstract: OBJECTIVE
  The association of idiopathic hypogonadotrophic hypogonadism (IHH) with congenital olfactory deficit defines Kallmann's syndrome (KS). Although a small proportion of IHH patients have been found to harbour defined genetic lesions, the genetic basis of most IHH cases remains to be elucidated. Genes currently recognized to be involved comprise KAL (associated with X-linked-KS), the GnRH receptor (associated with resistance to GnRH therapy), DAX 1 (associated with adrenohypoplasia congenita) and three loci also associated with obesity, leptin (OB), leptin receptor (DB) and prohormone convertase (PC1). Because of the rarity of the condition and the observation that patients are almost universally infertile without assistance, familial transmission of IHH is encountered infrequently and pedigrees tend to be small. This has constrained the ability of conventional linkage studies to identify other candidate loci for genetic IHH. We hypothesized that a systematic clinical evaluation of a large patient sample might provide new insights into the genetics of this rare disorder. Specifically, we wished to examine the following propositions. First, whether normosmic (nIHH) and anosmic (KS) forms of IHH were likely to be genetically discrete entities, on the basis of quantitative olfactory testing, analysis of autosomal pedigrees and the prevalence of developmental defects such as cryptorchidism and cleft palate. Second, whether mirror movements and/or unilateral renal agenesis were specific phenotypic markers for X-linked-KS.
  
  
  METHODS
  We conducted a clinical study of 170 male and 45 female IHH patients attending the endocrinology departments of three London University teaching hospitals. Approximately 80% of data were obtained from case records and 20% collected prospectively. Parameters assessed included olfaction, testicular volume, family history of hypogonadism, anosmia or pubertal delay, and history or presence of testicular maldescent, neurological, renal or craniofacial anomalies. Where possible, the clinical information was correlated with published data on genetic analysis of the KAL locus.
  
  
  RESULTS
  Olfactory acuity was bimodally distributed with no evidence for a spectrum of olfactory deficit. Testicular volume, a marker of integrated gonadotrophin secretion, did not differ significantly between anosmic and normosmic patients, at 2.0 ml and 2.2 ml, respectively. Nevertheless, the prevalence of cryptorchidism was nearly three times greater in anosmic (70.3%, of which 75.0% bilateral) than in normosmic (23.2%, of which 43.8% bilateral) patients. Individuals with nIHH, eugonadal isolated anosmia and/or KS were observed to coexist within 6/13 autosomal IHH pedigrees. On three occasions, fertility treatment given to an IHH patient had resulted in the condition being transmitted to the resulting offspring. Mirror movements and unilateral renal agenesis were observed in 24/98 and 9/87 IHH patients, respectively, all of whom were identifiable as X-KS males on the basis of pedigree analysis and/or defective KAL coding sequence. Abnormalities of eye movement and unilateral sensorineural deafness were observed in 10/21 and 6/111 KS patients, respectively, but not in nIHH patients.
  
  
  CONCLUSIONS
  Patients with IHH are almost invariably either anosmic (KS) or normosmic (nIHH), rather than exhibiting intermediate degrees of olfactory deficit. Moreover, the prevalence of cryptorchidism is nearly three times greater in KS than in nIHH despite comparable testicular volumes, suggesting a primary defect of testicular descent in KS independent of gonadotrophin deficiency. Disorders of eye movement and hearing appear only to occur in association with KS. Taken together, these findings indicate a clear phenotypic separation between KS and nIHH. However, pedigree studies suggest that autosomal KS is an heterogeneous condition, with incomplete phenotypic penetrance within pedigrees, and that some cases of autosomal KS, nIHH and even isolated anosmia are likely to have a common genetic basis. The prevalences of anosmia, mirror movements and unilateral renal agenesis among X-KS men are estimated to be 100, 85 and 31%, respectively. In sporadic IHH, mirror movements and unilateral renal agenesis are 100% specific phenotypic markers of de novo X-KS. By comparison, only 7/10 X-KS families harboured KAL coding defects. Clinical ascertainment, using mirror movements, renal agenesis and ichthyosis as X-KS-specific phenotypic markers, suggested that de novo X-KS was unlikely to comprise more than 11% of sporadic cases. The majority of sporadic KS cases are therefore presumed to have an autosomal basis and, hence, the preponderance of affected KS males over females remains unexplained, though reduced penetrance in women would be a possibility.
authors.affiliation: Department of Endocrinology, Royal Victoria Infirmary, Newcastle-upon-Tyne, UK. richard.quinton@ncl.ac.uk
authors.forename: R
authors.initials: R
authors.lastname: Quinton
authors.forename: V M
authors.initials: VM
authors.lastname: Duke
authors.forename: A
authors.initials: A
authors.lastname: Robertson
authors.forename: J M
authors.initials: JM
authors.lastname: Kirk
authors.forename: G
authors.initials: G
authors.lastname: Matfin
authors.forename: P A
authors.initials: PA
authors.lastname: de Zoysa
authors.forename: C
authors.initials: C
authors.lastname: Azcona
authors.forename: G S
authors.initials: GS
authors.lastname: MacColl
authors.forename: H S
authors.initials: HS
authors.lastname: Jacobs
authors.forename: G S
authors.initials: GS
authors.lastname: Conway
authors.forename: M
authors.initials: M
authors.lastname: Besser
authors.forename: R G
authors.initials: RG
authors.lastname: Stanhope
authors.forename: P M
authors.initials: PM
authors.lastname: Bouloux
mesh_terms: D000293:Adolescent; D000328:Adult; D019465:Craniofacial Abnormalities / Q000235:genetics; D020820:Dyskinesias / Q000235:genetics; D016326:Extracellular Matrix Proteins; D005260:Female; D008040:Genetic Linkage; D006062:Gonadotropins / Q000172:deficiency* / Q000235:genetics; D006801:Humans; D007006:Hypogonadism / Q000235:genetics*; D017436:Kallmann Syndrome / Q000235:genetics; D007668:Kidney / Q000002:abnormalities; D008297:Male; D009419:Nerve Tissue Proteins / Q000235:genetics; D000857:Olfaction Disorders / Q000235:genetics; D010375:Pedigree; D010641:Phenotype; D011446:Prospective Studies; D012189:Retrospective Studies; D014960:X Chromosome
chemical_list: C076266:ANOS1 protein, human; D016326:Extracellular Matrix Proteins; D006062:Gonadotropins; D009419:Nerve Tissue Proteins